These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 12432222)
21. The genetics of generalized vitiligo. Spritz RA Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890 [TBL] [Abstract][Full Text] [Related]
22. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo. Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578 [TBL] [Abstract][Full Text] [Related]
24. Neural differentiation as an expression of UV sensitivity of melanocytes. Iyengar B Acta Anat (Basel); 1992; 143(3):236-40. PubMed ID: 1632190 [TBL] [Abstract][Full Text] [Related]
26. Vitiligo. Le Poole C; Boissy RE Semin Cutan Med Surg; 1997 Mar; 16(1):3-14. PubMed ID: 9125760 [TBL] [Abstract][Full Text] [Related]
27. FK506 (tacrolimus) and endothelin combined treatment induces mobility of melanoblasts: new insights into follicular vitiligo repigmentation induced by topical tacrolimus on sun-exposed skin. Lan CC; Wu CS; Chen GS; Yu HS Br J Dermatol; 2011 Mar; 164(3):490-6. PubMed ID: 21039414 [TBL] [Abstract][Full Text] [Related]
28. In vitro migration of melanoblasts requires matrix metalloproteinase-2: implications to vitiligo therapy by photochemotherapy. Lei TC; Vieira WD; Hearing VJ Pigment Cell Res; 2002 Dec; 15(6):426-32. PubMed ID: 12453184 [TBL] [Abstract][Full Text] [Related]
29. Melanocyte destruction and repopulation in vitiligo. Norris DA; Horikawa T; Morelli JG Pigment Cell Res; 1994 Aug; 7(4):193-203. PubMed ID: 7855062 [No Abstract] [Full Text] [Related]
30. Vitiligo: a manifestation of apoptosis? Huang CL; Nordlund JJ; Boissy R Am J Clin Dermatol; 2002; 3(5):301-8. PubMed ID: 12069635 [TBL] [Abstract][Full Text] [Related]
31. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo. Yu HS; Wu CS; Yu CL; Kao YH; Chiou MH J Invest Dermatol; 2003 Jan; 120(1):56-64. PubMed ID: 12535198 [TBL] [Abstract][Full Text] [Related]
32. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of melanocyte-melanocyte stem cell lineage in vitiligo; a clue to interfollicular melanocyte stem cell reservoir. Seleit I; Bakry OA; Abdou AG; Dawoud NM Ultrastruct Pathol; 2014 May; 38(3):186-98. PubMed ID: 24460782 [TBL] [Abstract][Full Text] [Related]
34. Vitiligo: current medical and scientific understanding. Boissy RE; Nordlund JJ G Ital Dermatol Venereol; 2011 Feb; 146(1):69-75. PubMed ID: 21317859 [TBL] [Abstract][Full Text] [Related]
35. Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo. Webb KC; Eby JM; Hariharan V; Hernandez C; Luiten RM; Le Poole IC Exp Dermatol; 2014 Aug; 23(8):529-33. PubMed ID: 24840876 [TBL] [Abstract][Full Text] [Related]
36. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. Lee AY; Kim NH; Choi WI; Youm YH J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039 [TBL] [Abstract][Full Text] [Related]
37. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir. Dogra S; Kumar B Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926 [TBL] [Abstract][Full Text] [Related]
38. PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. Ortonne JP; Schmitt D; Thivolet J J Invest Dermatol; 1980 Jan; 74(1):40-2. PubMed ID: 7351492 [TBL] [Abstract][Full Text] [Related]
39. Development of melanocye-keratinocyte co-culture model for controls and vitiligo to assess regulators of pigmentation and melanocytes. Kumar R; Parsad D; Kanwar A; Kaul D Indian J Dermatol Venereol Leprol; 2012; 78(5):599-604. PubMed ID: 22960816 [TBL] [Abstract][Full Text] [Related]
40. The enigma and challenges of vitiligo pathophysiology and treatment. Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]